Sorrento Approved For $105M Scilex Stock Sale In Ch. 11

By Vince Sullivan · August 25, 2023, 7:32 PM EDT

Bankrupt drug developer Sorrento Therapeutics received approval Friday in Texas court for a $105 million sale of its stake in subsidiary Scilex Holding Co. after a bankruptcy judge declined to reopen...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login